Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human FGFR2 Antibodies:
anti-Mouse (Murine) FGFR2 Antibodies:
anti-Rat (Rattus) FGFR2 Antibodies:
Go to our pre-filtered search.
Human Monoclonal FGFR2 Primary Antibody for IHC (p), ELISA - ABIN560876
Ozawa, Yang, Ealy: The expression of fibroblast growth factor receptors during early bovine conceptus development and pharmacological analysis of their actions on trophoblast growth in vitro. in Reproduction (Cambridge, England) 2013
Show all 7 Pubmed References
Human Polyclonal FGFR2 Primary Antibody for FACS, IF - ABIN391965
Freeman, Gangula, Welm, Ozen, Foster, Rosen, Ittmann, Greenberg, Spencer et al.: Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase ... in Cancer research 2003
Show all 9 Pubmed References
Cow (Bovine) Polyclonal FGFR2 Primary Antibody for WB - ABIN611352
Steegmaier, Yang, Yoo, Huang, Shen, Yu, Luo, Scheller: Three novel proteins of the syntaxin/SNAP-25 family. in The Journal of biological chemistry 1999
Show all 2 Pubmed References
Human Monoclonal FGFR2 Primary Antibody for CyTOF, FACS - ABIN4900757
Rossi, Jeker, Ueno, Kuse, Keller, Zuklys, Gudkov, Takahama, Krenger, Blazar, Holländer: Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. in Blood 2007
Show all 2 Pubmed References
Human Monoclonal FGFR2 Primary Antibody for CyTOF, FACS - ABIN4900758
Di Maggio, Mehrkens, Papadimitropoulos, Schaeren, Heberer, Banfi, Martin: Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c. in Stem cells (Dayton, Ohio) 2012
Show all 2 Pubmed References
Human Polyclonal FGFR2 Primary Antibody for ELISA, WB - ABIN314240
McGrath, Lee, Buring, Hunter, De Vivo: Novel breast cancer risk alleles and endometrial cancer risk. in International journal of cancer 2008
Human Monoclonal FGFR2 Primary Antibody for CyTOF, FACS - ABIN4900756
Ponte, Marais, Gallay, Langonné, Delorme, Hérault, Charbord, Domenech: The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. in Stem cells (Dayton, Ohio) 2007
Human Polyclonal FGFR2 Primary Antibody for IHC, IHC (p) - ABIN4311537
Tchaicha, Akbay, Altabef, Mikse, Kikuchi, Rhee, Liao, Bronson, Sholl, Meyerson, Hammerman, Wong: Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC. in Cancer research 2014
Description of these patients expands the prenatal and postnatal findings of Bent Bone Dysplasia-FGFR2 type and adds to the phenotypic spectrum among all FGFR2 disorders.
Our results imply that the same FGFR2 mutations result in diverse phenotypes, and that genetic studies are recommended not only for obviously affected individuals but also for family members with apparently normal phenotype or non-specific subtle abnormal phenotype.
Liensinine inhibits FGFR2 activity.
The frequent expression of members of the FGFR family in cervical cancer suggests they may have prognostic and therapeutic relevance.
FGFR2-ACSL5 (show ACSL5 Antibodies) fusion is associated with resistance to LY2874455 in FGFR2-amplified gastric cancer .
FGFR2 mutation is associated with endometrial carcinoma progression and abdominopelvic metastasis.
FGFR inhibitors, particularly BGJ398, are therapeutic options for cholangiocarcinoma patients harboring FGFR2-CCDC6 (show CCDC6 Antibodies) fusions.
High FGFR2 expression is associated with Gastric Cancers.
FGF7 (show FGF7 Antibodies) stimulation of cell invasion and migration was partially suppressed by the FGFR2 knockdown. In addition, FGF7 (show FGF7 Antibodies)/FGFR2 upregulated THBS1 (show THBS1 Antibodies), and cell invasion and migration were decreased by knockdown of THBS1 (show THBS1 Antibodies)
Two novel FGFR 2 gene missense mutations in Chinese patients with Crouzon syndrome were identified.
FGFR2 signalling correlates with maintenance of expression of a key transcription factor for basal cell self-renewal and differentiation: SOX2 (show SOX2 Antibodies).
Fgfr2 is seen within submucosal glandular epithelial cells. The medial nasal glands were missing in Fgfr2b mutants.
It is well accepted that myelin is a biologically active membrane in active communication with the axons. However, the axonal signals, the receptors on myelin, and the integration of intracellular signaling pathways emanating downstream from these receptors that drive the growth of the myelin sheath remain poorly understood in the CNS. This study brings up the intriguing possibility that FGF receptor 2, in the oligodendr
data suggest that FGF2 (show FGF2 Antibodies) levels are critically related to anxiety behavior and hypothalamic pituitary- adrenal axis activity, likely through modulation of hippocampal glucocorticoid receptor (show NR3C1 Antibodies) expression, an effect that is likely receptor mediated, albeit not by FGFR1 (show FGFR1 Antibodies), FGFR2, and FGFR3 (show FGFR3 Antibodies).
Results show that Fgfr2 regulates both the formation and resolution of tetrads and rosettes in the mouse embryo, possibly in part by spatially restricting atypical protein kinase C (show PRKCZ Antibodies), a negative regulator of non-muscle myosin IIB (show MYH10 Antibodies).
FGFR2c signaling regulates branching morphogenesis through the activation of FGFR2b signaling via increased FGF10 (show FGF10 Antibodies) autocrine. These results provide new insight into the mechanisms by which crosstalk between FGFR2b and FGFR2c results in efficient branching morphogenesis.
Fgfr2 is critical for bladder mesenchyme patterning by virtue of its role in modulation of hedgehog (show SHH Antibodies) signaling
Ectopic expression of Fgfr2c was detected within the affected sutures of Bcl11b (show BCL11B Antibodies)(-/-) mice. Ectopic expression of Fgfr2c in the sutural mesenchyme, without concomitant changes in the expression of FGF ligands, appears to induce the RUNX2 (show RUNX2 Antibodies)-dependent osteogenic program and craniosynostosis in Bcl11b (show BCL11B Antibodies)(-/-) mice.
Calvarial osteoblasts from Fgfr2c gain-of-function mice had enhanced osteoblastic function and maturation with concomitant increase in ERK-MAPK (show MAPK1 Antibodies) activation. In vitro inhibition with U0126 mitigated ERK (show EPHB2 Antibodies) protein activation levels and reduced alkaline phosphatase activity. FGFR2c-mediated ERK-MAPK (show MAPK1 Antibodies) signaling is a key mediator of craniofacial growth and coronal suture development.
Fgfr1 (show FGFR1 Antibodies) and Fgfr2 in the palatal and mandibular mesenchyme have roles in regulating shelf medial wall protrusion and growth of the mandible to coordinate the craniofacial tissue movements that are required for palatal shelf elevation
mRNA and protein expression of FGFR-1 (show FGFR1 Antibodies), FGFR-2 in the porcine umbilical cord during pregnancy.
EGFR (show EGFR Antibodies), VEGFR (show KDR Antibodies) and FGFR are expressed in porcine oviduct and endometrium during the time of implantation [review]
analysis of regulation of endometrial fibroblast growth factor 7 (FGF-7 (show FGF7 Antibodies)) and its receptor FGFR2IIIb
it is highly likely that the missense mutation in the FGFR2 gene caused the bovine facial dysplasia syndrome phenotype in a dominant mode of inheritance.
FGF10 (show FGF10 Antibodies) and its receptor FGFR2b are more expressed in subordinate follicles; FGF10 (show FGF10 Antibodies) acts as an important regulator of follicular growth in cattle.
Alterations in the expression of VEGF-A (show VEGFA Antibodies) and bFGF (show FGF2 Antibodies) systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.
These data support a role for FGF10 (show FGF10 Antibodies) and fibroblast growth factor receptor 2B in signaling to granulosa cells from theca cells and/or the oocyte.(fibroblast growth factor receptor 2B)
FGF10 (show FGF10 Antibodies) mRNA expression did not change during functional luteolysis, whereas FGFR2B mRNA abundance decreased significantly at 2, 4, and 12 hr after PGF2alpha, and returned to pretreatment levels for the period 24-64 hr post-PGF2alpha
we show that minimal amounts of Fgfr1a or Fgfr2 are required to initiate a regulatory cascade in pharyngeal endoderm reducing expression of fsta, thereby allowing correct BMP signaling to the maturing chondrocytes of the head cartilage.
the roles of Fgfr2 signaling in zebrafish left-right asymmetry
The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
fibroblast growth factor receptor 2
, bacteria-expressed kinase
, keratinocyte growth factor receptor
, fibroblast growth factor receptor 2 IIIb
, fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome)
, BEK fibroblast growth factor receptor
, FGF receptor
, hydroxyaryl-protein kinase
, protein tyrosine kinase, receptor like 14
, soluble FGFR4 variant 4
, FGF-7 receptor 2IIIb
, fgf receptor
, chicken tyrosine kinase (cek3)
, receptor tyrosine kinase
, tyrosine kinase receptor CEK3
, fibroblast growth factor receptor-2